- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Five EHR Products Receive Meaningful Use Certification
Five health information technology vendors have recently received certification of specific products meeting Stage 1 electronic health records meaningful use criteria.
“Complete EHR” certification means a product supports all ambulatory or inpatient meaningful use requirements. “EHR Module” certification means an ancillary application meets one or more requirements. The recently certified products, all tested by Drummond Group, include:
* ADS Technologies’ Supra, version 4.0, as a Complete EHR;
* Virco Lab’s AVIGA for HIV/AIDS care, version 1.0, as an EHR Module;
* IOD Incorporated’s PRISM release of information software, version 6.0, as an EHR Module;
* Streamline Health’s AccessAnyWare HIM software, version 1.9, as an EHR Module; and
* Hyland Software’s OnBase HIM software, version 11.0, as an EHR Module.
Read more at: http://www.healthdatamanagement.com/news/ehr-electronic-health-records-meaningful-use-onc-43828-1.html
Source: Health Data Management
Understanding How Fitness Affects Digestive Diseases
April 18th 2025Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ease gut inflammation, reduce colorectal cancer risk, and relieve constipation, while intense workouts may backfire, causing reflux, GI bleeding, or gut barrier disruption.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
